Back to catalogue
№ 283 39 filings · 2021-09-14 → 2026-09-24

MERCIA ASSET MANAGEMENT PLC

MERC
Financial Services Share price 31.00p Market cap £130m Overall fit 260 /1000

Reasonable valuation discount and quality balance sheet, but essentially no AI-beneficiary exposure, only modest operating leverage, and the catalyst (portfolio realisation) has slipped repeatedly — doesn't fit the AI-receiver/operating-leverage thesis the investor is building around.

Fair value range 32p–40p Mid case · £151m
Absolute upside +16.1% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Clean audited financials with transparent investee-level marks
  • Recurring, growing fund-management EBITDA
  • Explicit balance-sheet cash and net cash bridge
Limits the call
  • 68% of assets are Level 3 with unknowable exit prices
  • Direct-portfolio divestiture timing entirely unspecified
Methodology

Sum-of-parts (FM business multiple + discounted portfolio + net cash) less holdco discount

In one line · bull case

Cheap on sum-of-parts with a growing recurring fund-management engine and a specific catalyst (direct-portfolio divestiture) that would collapse the NAV discount.

In one line · biggest risk

Direct portfolio is Level 3 and could be sold materially below book, permanently narrowing the SOTP rather than closing the discount.

Drivers
AI beneficiary 15 /100
Backs UK regional SMEs; portfolio has occasional AI-flavoured names (Netacea cyber) but Mercia itself captures no AI value chain economics.
Operating leverage 50 /100
Real leverage on next AuM tranche (H1 FY26 showed 14% EBITDA growth on -4% revenue) but bounded by need to hire investment staff for larger funds.
Earnings vs expectations 55 /100
Recent EBITDA beats and 'materially ahead' FY25 update, but Mercia 20:20 PBT target was materially missed.
Growth momentum 45 /100
Organic FuM growth modest at 1-2% p.a.; growth is scale-and-margin story rather than top-line acceleration.
Moat 40 /100
11-office regional footprint, BBB and VCT relationships and closed-end fund lock-ins provide narrow moat, not deep.
Earnings quality 55 /100
c.80% recurring revenue but 68% of assets are Level 3 subject to management judgement; EBITDA is a cleaner metric than IFRS profit.
Management quality 55 /100
10-year track record of building AuM from £23m to £2.2bn, transparent disclosure, but missed prior strategic targets.
Cyclicality 55 /100
Fee income sticky (closed-end funds, no redemptions) but performance fees, exit gains and fundraising all move with cycles.
Leverage 20 /100
£37m gross cash offset by £16m drawn on new £38m facility; still net cash and no leverage stress.
Value-trap signals · 4
  • Persistent >30% NAV discount for 3+ years
  • Direct portfolio realisation 'conversations' referenced across multiple periods without headline deals
  • Level 3 marks with recent full write-offs (sureCore) and prior large impairments (Impression Technologies FY24)
  • Previous Mercia 20:20 PBT target missed materially

Mercia Asset Management PLC (MERC) — Investment Research Note

Executive summary

Mercia is a UK-focused private capital asset manager with c.£2.2bn AuM across venture, development capital, property finance and its own balance-sheet investments, serving regional SMEs from 11 UK offices 2026-09-24 AGM. Across the reporting window it has grown FuM from c.£23m at IPO (2014) to c.£1.8bn today via a mix of organic wins (BBB regional mandates, VCT/EIS raises) and two acquisitions (FDC, VCT contracts), while the direct investment portfolio has been repositioned as non-core and is being wound down for eventual divestiture 2025-12-02 interim, 2024-07-26 reclassification notice. The single most important valuation point today is the wide gap between the 27.5p share price and 43.4p per-share NAV — the market applies a c.37% discount to book that reflects both illiquid Level-3 portfolio marks and doubts about realisation timing.

Fair value estimate

Range: 32p – 40p per share; implied market cap £135m – £168m (mid £151m).

Methodology: sum-of-parts. Two building blocks:

  1. Fund management business — H1 FY26 annualised EBITDA c.£8.4m (£4.2m x 2) 2025-12-02 interim; Mercia '27 target £10m. Apply 9–11x on run-rate EBITDA of £8–9m → £72–99m (£85m mid). Sticky closed-end/evergreen fund structures, no redemptions, 80% recurring revenue support the multiple.
  2. Direct investment portfolio — £131.1m book value, Level-3 (79% based on last-round price or market multiple) 2025-12-02 interim. Apply 25–35% discount reflecting illiquidity and forced-seller optics from stated divestiture intent → £85–98m (£92m mid).
  3. Net financial position — £37m gross cash less £16m drawn on the new £38m bank facility → £21m net cash 2026-09-24 AGM.
  4. Less deferred tax £2.7m and lease liabilities £1.2m → –£4m.

Aggregate equity value: £174m – £212m (£194m mid). Applying a 20–25% holding-company discount (typical for listed alt-asset managers with unrealised portfolios) yields £135m–£168m, or 32–40p/share.

Vs latest market cap £115.7m → absolute upside c.30% at mid.

Sector context

Financial Services / specialist alternative asset manager. Quality profile is in line with, but scale is well below, listed UK peers such as Intermediate Capital Group, Bridgepoint, Foresight Group and Gresham House (now delisted). Mercia is smaller, has a bigger relative balance-sheet portfolio (a legacy hybrid model peers have shed), and a more retail/public-sector-weighted FuM mix. Its EBITDA margin (24.6% H1 FY26) is below scaled peers (typically 35–50%), reflecting sub-scale and continuing investment in a 130-person team across 11 offices.

Investment thesis

  1. Steep discount to demonstrable book, with a defined catalyst — the shares trade at 63% of a NAV that is anchored by £37m cash and a £131m portfolio being actively marketed for divestiture. Management explicitly stated conversations are underway on the potential sale of the direct portfolio 2026-09-24 AGM. A single realisation event closer to book would collapse the discount.
  2. Cash-generative fund management engine with visible operating leverage runway — H1 FY26 EBITDA up 14% on 4% lower revenue, EBITDA margin expanded to 24.6% from 20.8% via automation and lower headcount 2025-12-02 interim. Targeted 26% margin by March 2027 on higher AuM (£3bn goal) implies continued incremental margin expansion.
  3. Structural tailwinds from UK regional/Mansion House allocations — Mercia has just been awarded a £63m initial East of England Investment Fund mandate under BBB 2026-09-24 AGM, adding to a £550m institutional pipeline. Increased LGPS pooling and place-based investment mandates favour incumbent regional managers 2025-12-02 interim.

Key risks

  1. Direct-portfolio realisation risk — the £131m portfolio is dominated by unquoted software/deep-tech/life-science holdings that have already seen impairments (sureCore fully written off H1 FY26; Netacea and VirtTrade modest impairments) 2025-12-02 interim. Sales could clear meaningfully below book, permanently narrowing the SOTP.
  2. AIM small-cap liquidity and structural share overhang — market cap £116m, low daily volume, £3m/yr buyback is small relative to any institutional exit; a 74m-share director aggregate holding 2024-07-26 AGM notice creates concentration.
  3. Missed prior strategic targets — the previous "Mercia 20:20" £60m cumulative PBT target was missed 2023-11-28 interim admits this. Mercia '27 goals (£3bn AuM, £10m EBITDA, 26% margin) may again slip if fundraising markets stay subdued, which management flagged for EIS in H1 FY26 2025-12-02 interim.

Operating leverage

Cost base is dominated by staff (c.£19m of £27m FY25 admin expenses, ~70%) and offices — largely fixed once AuM tier is set. Incremental AuM at existing infrastructure carries high contribution margin: recent evidence is H1 FY26, where a 3.9% revenue decline still produced a 14% EBITDA increase because staff and admin cost fell more sharply as post-mandate-win hiring wound down 2025-12-02 interim CFO review. Management's own arithmetic — moving from FY25 £7.6m EBITDA (22% margin) to FY27 £10m EBITDA (26% margin) on c.£38m revenue — implies incremental EBITDA margin of 80% on the next c.£3m of revenue. A 10–20% upside surprise to AuM above plan (£300–600m extra FuM at typical 1% fee = £3–6m extra revenue) could plausibly add £2–5m to EBITDA, i.e. a 25–60% incremental EBITDA uplift. Operating leverage is real but bounded by the need to hire investment professionals for materially larger fund vintages — genuinely capital-light platform-style leverage does not apply here.

Value-trap signals

  • Direct-portfolio marks are inherently subjective (Level 3, based on last-round price or model multiples) with a poor recent track record: FY24 saw a £17.3m unrealised loss and one investment fully written off in H1 FY26.
  • The previous three-year strategic PBT target was missed by a wide margin 2023-11-28 interim.
  • Persistent NAV discount for 3+ years suggests the market has structurally derated the shares rather than being a temporary mispricing.
  • Direct-portfolio realisation "conversations" have been referenced for multiple reporting cycles without a headline deal.

Earnings vs. expectations

Formal analyst consensus is not disclosed in filings, but management's own guidance is trackable:

  • FY25 — April 2025 trading update stated EBITDA "materially ahead of current market expectations" 2025-04-16 trading update. Delivered: FY25 EBITDA £7.6m vs H1 FY25 run-rate implying ~£7.4m — a modest beat.
  • H1 FY26 — no specific pre-guide, but revenue -3.9% vs prior-year comparative was a modest miss on top-line; EBITDA +14% was a clear beat on profitability.
  • Mercia '20:20 three-year plan (FY22-FY24) — cumulative £60m PBT target missed materially; explicitly conceded in H1 FY24 2023-11-28 interim.

Pattern: mixed — operational cost delivery beats, but ambitious multi-year AuM/PBT targets tend to slip.

Conviction

3 — moderate. Supports: (a) clean audited accounts and unqualified BDO reviews across the window; (b) transparent AuM/liquidity disclosures with granular investee-level fair values; (c) sum-of-parts arithmetic is not exotic and the fund management earnings are recurring. Limits: (a) 68% of assets are Level 3 direct investments whose exit prices are genuinely unknowable from filings; (b) timing of the flagged direct-portfolio divestiture is completely unspecified, which drives whether the discount is a 12-month or 5-year catalyst.

Filings consulted · 40

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-24Result OF Agm2026-09-24_9789367_result-of-agm.md0.30
  2. 2026-09-24Agm Statement2026-09-24_9787945_agm-statement.md0.40
  3. 2026-07-24Publication OF Annual Report And Notice OF Agm2026-07-24_9685232_publication-of-annual-report-and-notice-of-agm.md0.95
  4. 2026-06-17Investor Presentation2026-06-17_9621957_investor-presentation.md0.70
  5. 2025-12-02Interim Results2025-12-02_9269008_interim-results.md0.77
  6. 2025-11-18Investor Presentation2025-11-18_9239899_investor-presentation.md0.59
  7. 2025-10-22Notice OF Interim Results2025-10-22_9185874_notice-of-interim-results.md0.77
  8. 2025-09-25Result OF Agm And Directorate Change2025-09-25_9131905_result-of-agm-and-directorate-change.md0.20
  9. 2025-09-25Agm Statement2025-09-25_9130073_agm-statement.md0.26
  10. 2025-07-25Publication OF Annual Report And Notice OF Agm2025-07-25_8999968_publication-of-annual-report-and-notice-of-agm.md0.62
  11. 2025-06-04Investor Presentation2025-06-04_8910982_investor-presentation.md0.46
  12. 2025-04-16Trading Update And Notice OF Results2025-04-16_8833111_trading-update-and-notice-of-results.md0.55
  13. 2024-11-26Interim Results2024-11-26_8572005_interim-results.md0.58
  14. 2024-11-19Investor Presentation2024-11-19_8557912_investor-presentation.md0.46
  15. 2024-10-24Notice OF Interim Results2024-10-24_8505346_notice-of-interim-results.md0.58
  16. 2024-09-26Result OF Agm2024-09-26_8441793_result-of-agm.md0.20
  17. 2024-09-26Agm Statement2024-09-26_8440085_agm-statement.md0.26
  18. 2024-07-26Publication OF Annual Report And Notice OF Agm2024-07-26_8332330_publication-of-annual-report-and-notice-of-agm.md0.43
  19. 2023-11-28Interim Results2023-11-28_7906251_interim-results.md0.41
  20. 2023-11-23Investor Presentation2023-11-23_7898282_investor-presentation.md0.32
  21. 2023-10-12Notice OF Interim Results2023-10-12_7811446_notice-of-interim-results.md0.41
  22. 2023-09-21Result OF Agm2023-09-21_7769802_result-of-agm.md0.07
  23. 2023-09-21Agm Statement2023-09-21_7768453_agm-statement.md0.10
  24. 2023-07-28Publication OF Annual Report And Notice OF Agm2023-07-28_7660580_publication-of-annual-report-and-notice-of-agm.md0.24
  25. 2023-06-28Investor Presentation2023-06-28_7599005_investor-presentation.md0.17
  26. 2022-12-20Ndreams Continues Its Progress With Acquisition2022-12-20_7184528_ndreams-continues-its-progress-with-acquisition.md0.19
  27. 2022-12-06Interim Results2022-12-06_7319169_interim-results.md0.23
  28. 2022-12-06Acquisition OF Frontier Development Capital2022-12-06_7319166_acquisition-of-frontier-development-capital.md0.19
  29. 2022-11-22Investor Presentation2022-11-22_7422628_investor-presentation.md0.17
  30. 2022-10-25Notice OF Interim Results2022-10-25_7156818_notice-of-interim-results.md0.23
  31. 2022-09-13Result OF Agm2022-09-13_7313381_result-of-agm.md0.07
  32. 2022-09-13Agm Statement2022-09-13_7311808_agm-statement.md0.10
  33. 2022-07-29Publication OF Annual Report And Notice OF Agm2022-07-29_6916507_publication-of-annual-report-and-notice-of-agm.md0.24
  34. 2022-06-27Investor Presentation2022-06-27_7071433_investor-presentation.md0.17
  35. 2021-12-07Interim Results2021-12-07_6754287_interim-results.md0.23
  36. 2021-11-25Nvt Performance Fee Entitlement And Trading Update2021-11-25_6591316_nvt-performance-fee-entitlement-and-trading-update.md0.21
  37. 2021-11-22Investor Presentation2021-11-22_6835608_investor-presentation.md0.17
  38. 2021-10-27Notice OF Interim Results2021-10-27_6571221_notice-of-interim-results.md0.23
  39. 2021-09-14Result OF Agm2021-09-14_6826347_result-of-agm.md0.03
  40. 2021-09-14Agm Statement2021-09-14_6825429_agm-statement.md0.04

This research note was authored by a large language model after reading 39 regulatory filings published between 2021-09-14 and 2026-09-24. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.